- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02027675
Meal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and Inflammation (MERIIT)
In a society where exercise is prescribed by physicians to increase physical condition, improve dietary habits and reduce cardiovascular risk, the impact of exercise, acute or chronic, and diet in inflammation and immunity is unknown. Specific populations can have different responses towards acute and chronic exercise. Moreover specific conditions, like the type of meal ingested, can interfere with these responses. The true effect of pre-competitive meal exercise in the immunity and inflammatory response is unknown. Acute physical inactivity periods, commonly happens during daily life, related to work or acute illness. New evidence points out that it induces immediate metabolic and endocrinological changes, these can might also be associated with changes in immune response.
Aims of this project are:
- to assess the effect of the precompetitive meal on the inflammatory, neuro-immune and metabolic response to exercise;
- to assess the effects of sedentary behaviour on inflammatory, neuro-immune and metabolic response;
- to assess differences in changes between healthy, asthmatic and obese subjects
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Two interventions will be performed for assessing the research questions and aims:
A) Randomized cross-over, with a wash out period of 7 days, single-blinded trial where two different pre-competitive meals will be followed by an exercise challenge; inflammatory neuro-immune and metabolic response will be assessed before and after each challenge.
Participants will be recruited from advertisement and four different groups will be compared: obese-asthmatic; asthmatic non-obese; obese without asthma and non-asthmatic and non-obese. All patients will be allocated to a meal challenge in which a high fat poor micronutrient meal followed by a Mediterranean meal or vice-versa; meal challenge order will be randomized and participants will be blinded to the intervention. The main outcome for this intervention will be airway inflammation and lung function. All outcomes will be assessed before and 3h after each meal.
A group of individuals will, in the three hours after the meal, perform an exercise challenge, which is aimed to induce acute immune changes.
B) Randomized controlled trial where participants, after a run-in period and eligibility evaluation, will be allocated to an intervention consisting in a reduction of physical activity by 50% or maintaining habitual physical activity for two weeks; inflammatory neuro-immune and metabolic response will be assessed before and after intervention.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Porto, Portogallo, 4200
- Faculty of Nutrition and Food Sciences of the University of Porto
-
Porto, Portogallo, 4200
- Faculty of Sports of Porto University
-
-
Porto
-
Portugal, Porto, Portogallo, 4200
- Faculty of Medicine of Porto University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- controlled mild to moderate asthma;
- Body mass index (BMI) ≥ 25 kg/m2; healthy participants (non asthmatic with a BMI 18,5 to 25 kg/m2) will be used for comparison;
Exclusion Criteria:
- respiratory disease other than asthma;
- severe asthma according to Global Initiative for Asthma (GINA) guidelines
- occurrence in previous 4 weeks of screening of upper/lower respiratory tract infection;
- smoking in the past 6 months and requiring mechanical ventilation for respiratory event within 6 months of screening.
- Medical conditions (hematologic, cardiovascular, renal, hepatic, neurologic or metabolic) or medication that may interfere with meal or physical activity intervention;
- Significant chronic infectious diseases (eg, HIV, hepatitis B or C);
- Abnormal electrocardiogram screening, cardiac arrhythmia, angina, congestive heart failure; renal or hepatic failure and systemic disease, mal-absorption disease history or intestinal inflammatory disease;
- Women breast-feeding, pregnant or intending pregnancy during study
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Meal Exercise Challenge- Order 2
Two different meals,an high fat micronutrient poor meal and Mediterranean Meal will be followed by an exercise challenge and performed at different orders accordingly to the cross over design.
|
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an high fat poor micronutrient meal.
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an Mediterranean meal
|
|
Sperimentale: Meal Exercise Challenge- Order 1
Two different meals,an high fat micronutrient poor meal and Mediterranean Meal will be followed by an exercise challenge and performed at different orders accordingly to the cross over design. Each arm corresponds to a different intervention order. |
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an high fat poor micronutrient meal.
The meal will be prepared by a team of nutritionist in order to comply with the demand characteristics of an Mediterranean meal
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Airway inflammation
Lasso di tempo: Up to 6 months
|
|
Up to 6 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Autonomic nervous system response
Lasso di tempo: Up to 6 months
|
Rest heart rate; pupillary response, before and after challenge Neuropeptides measurement
|
Up to 6 months
|
|
Oxidative stress biomarkers
Lasso di tempo: Up to 6 months
|
Assessment of plasma F2-isoprostanes, lipid hydroperoxides, protein carbonyls, hydrogen peroxide and lipid soluble antioxidants
|
Up to 6 months
|
|
Circulating blood leukocyte-total and differential leukocyte counts and lymphocyte subpopulations assessment.
Lasso di tempo: Up to 6 months
|
Evaluated by flow cytometry: T cell (CD4+/CD8+), and their subsets; B cells (CD19+), Natural Killer (NK) cells (CD16+/56+), their subsets; monocytes subsets; oxidative burst activity
|
Up to 6 months
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Histamine skin test reactivity
Lasso di tempo: Up to 6 months
|
Histamine skin test reactivity, assessed by skin prick test response
|
Up to 6 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Diana Silva, MD, Faculty of Medicine of Porto University
- Investigatore principale: Rita Moreira, Faculty of Nutrition and Food Sciences of the University of Porto
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MERIIT project
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .